Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. It serves as a building block in medicinal chemistry due to its ability to form stable heterocyclic structures that interact with biological targets. Commonly employed in the preparation of active pharmaceutical ingredients (APIs) where the bromo group allows for further functionalization via cross-coupling reactions such as Suzuki or Buchwald-Hartwig aminations. Also utilized in research settings for the design of new bioactive molecules with potential anxiolytic, anticonvulsant, or anti-inflammatory properties. Its rigid aromatic framework enhances binding selectivity and metabolic stability in drug candidates.